Dinani apa kuti muwonetse zikwangwani ZANU patsamba lino ndikulipira kuti mupambane

Waya News

Metformin Diso Madontho Ochizira Macular Degeneration

Written by mkonzi

Curative Biotechnology, Inc. yalengeza lero kuti kampaniyo yapita patsogolo mu kafukufuku wake wa Toxicology wa Good Laboratory Practice (GLP).

Kafukufuku wapano adapangidwa kuti aziyesa kulekerera, ma pharmacokinetics ndi kawopsedwe kalikonse kamene kamakhala m'deralo kapena kachitidwe ka metformin kamene kamayendetsedwa ndi kuperekedwa kwapamaso. Phunziroli lidzawunikanso kufalikira kwa minofu ya m'maso.

Kafukufuku wa toxicology wa Good Laboratory Practice (GLP) ndiwofunikira pakulemba kwa FDA Investigational New Drug (IND).

Kulekerera kwa maso kumaphatikizanso kuwunika kwa dosing, kuwunika kwachipatala kawiri tsiku lililonse (kuwunika kwa machitidwe/zizindikiro zachipatala ndikuyang'anitsitsa maso), kuyezetsa maso ndi dokotala wamaso wovomerezeka ndi Board-certified Veterinary ophthalmologist malinga ndi sikelo yosinthidwa ya Hackett-McDonald, ndi ocular histopathology. .

Pansi pa mgwirizano wa Cooperative Research and Development Agreement (CRADA), National Eye Institute (NEI) ndi Curative Biotechnology, Inc. adzagwirizana kuti awunike mawonekedwe a Curative ocular metformin m'maphunziro azachipatala pochiza matenda apakati komanso ochedwa Age-Related Macular Degeneration. (AMD) matenda.

Nkhani Zogwirizana

Ponena za wolemba

mkonzi

Mkonzi wamkulu wa eTurboNew ndi Linda Hohnholz. Amakhala ku eTN HQ ku Honolulu, Hawaii.

Siyani Comment

Gawani ku...